Jeff Atwater, Chief Finance Officer of Florida, Cornelia Quennet-Thielen, German State Secretary of the Federal Ministry of Education and Research, Prof. Peter Gruss, Max Planck Society President, and Dr. David Fitzpatrick, the Max Planck Florida Institute Scientific Director and CEO, opened the brand new Max Planck Florida Institute for Neuroscience (MPFI) at an official ceremony in Jupiter, Florida. It is the first institute of the Max Planck Society, which is based in Germany, to be located in the United States.
Recent PostsMonday, October 13, 2014
The University of Florida’s Multi-functional Integrated System Technology (MIST) Center will play a leading role in researching the next generation of “smart” electronics funded by a National Science Foundation program that combines federal money with industry investments in strategic research. ..Read More ⇒Sunday, October 12, 2014
VGTI Florida, a leading, non-profit biomedical research institute, announced the launch of its Center for Diseases of Aging (“CDA”), a major initiative to accelerate the discovery and advancement of novel, best-in-class healthcare interventions for the prevention and treatment of diseases commonly associated with aging. ..Read More ⇒Friday, October 10, 2014
Researchers at the University of Central Florida set a new record in funded research in FY14, receiving $145.6 million, 30 percent more than the previous year. The funding totals reflect successful collaborations with industry, a record total for federal defense grants and continued growth in commercialization and innovation activity. ..Read More ⇒Thursday, October 09, 2014
A team of scientists led by Sanford-Burnham’s Ranjan J Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of more-sensitive and specific non-invasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics. ..Read More ⇒Wednesday, October 08, 2014
The University of Florida announced today the formation of the UF Diabetes Institute, a collaboration of dozens of researchers campuswide all focused on forging advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians. ..Read More ⇒
TagsUniversity of Central Florida awards Florida Atlantic University VGTI Moffitt Cancer Center grants magnets FL Institute for Commercialization of Public Research accolades HIV/AIDS aerospace accreditation Florida Power & Light Max Planck AGTC gender marine Enterprise Florida clean energy Sanford-Burnham Draper accounting sustainability partnerships education research IHMC Univeristy of South Florida environment ICFO engineering AxoGen aging Nova Southeastern Univ. Florida Institute of Technology life science animals Florida State University physics consumers University of Miami FAMU robotics technology Torrey Pines Institute Embry-Riddle Florida Trend astronomy agriculture biotechnology photonics research policy Banyan Biomarkers Florida International Univ. Florida Gulf Coast Univ. economy BioFlorida health care Scripps Research Institute cancer bioscience innovation stem cell energy health children ecology University of West Florida green technology conference / event policy nanotechnology materials science commercialization computer science medical Nanotheraputics GrowFL Florida Hospital University of Florida Jackson Lab business neuroscience biomedical University of North Florida sciences society/culture